Document:

Warrant issued by GigOptix, Inc. to Bridge Bank, N.A.

 Exhibit 4.3 
 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE
REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED. 

WARRANT TO PURCHASE STOCK 
 Issuer: GIGOPTIX, INC., a Delaware corporation (the “Company”) 
 Number
of Shares: 20,000, as the same may be from time to time adjusted pursuant to Article 2 hereof. 
 Class of Stock: Common Stock
(the “Shares”) 
 Exercise Price: $3.65, as the same may be from time to time adjusted pursuant to Article 2 hereof.

 Issue Date: April 7, 2010 
 Expiration Date: April 7, 2017 
 THIS WARRANT CERTIFIES THAT, for the agreed
upon value of $1.00 and for other good and valuable consideration, BRIDGE BANK, NATIONAL ASSOCIATION (“Holder”) is entitled to purchase the number of fully paid and nonassessable Shares of the Company at the Exercise Price per Share set
forth, subject to the provisions and upon the terms and conditions set forth in this Warrant. 
  

	 ARTICLE 1
	 EXERCISE. 

 1.1 Method of Exercise. This Warrant is exercisable, in whole or in part, at any time and from time to time on or before the Expiration Date set forth above. Holder may exercise this Warrant by
delivering a duly executed Notice of Exercise, in substantially the form attached as Appendix 1, to the principal office of Company. Unless Holder is exercising the conversion right set forth in Section 1.2, Holder shall also
deliver to Company a check for the aggregate Exercise Price for Shares being purchased. 
 1.2 Conversion
Right. In lieu of exercising this Warrant as specified in Section 1.1, Holder may from time to time convert this Warrant, in whole or in part, into a number of Shares determined by dividing (a) the aggregate fair market value of Shares
or other securities otherwise issuable upon exercise of this Warrant minus the aggregate Exercise Price of such Shares by (b) the fair market value of one Share. The fair market value of Shares shall be determined pursuant to Section 1.3.

 1.3 Fair Market Value. If the Shares are traded in a public market, the fair market value of the
Shares shall be the closing price of the Shares (or the closing price of the Company’s stock into which the Shares are convertible) reported for the business day immediately before Holder delivers its Notice of Exercise to the Company. If the
Shares are not traded in a public market, the Board of Directors of Company shall determine fair market value in its reasonable good faith judgment The foregoing notwithstanding, if Holder advises the Board of Directors in writing that Holder
disagrees with such determination, then Company and Holder shall promptly agree upon a reputable investment banking firm to undertake such valuation. If the valuation of such investment banking firm is greater than that determined by the Board of
Directors, then all fees and expenses of such investment banking firm shall be paid by Company. In all other circumstances, such fees and expenses shall be paid by Holder. 

1.4 Delivery of Certificate and New Warrant. Promptly after Holder exercises or converts this Warrant, Company
shall deliver to Holder certificates for Shares acquired and, if this Warrant has not been fully exercised or converted and has not expired, a new Warrant representing Shares not so acquired. 

1.5 Replacement of Warrants. On receipt of evidence reasonably satisfactory to Company of the loss, theft,
destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to Company or, in the case of mutilation, on surrender and cancellation of
this Warrant, Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor. 
 1.6 Repurchase on Sale, Merger, or Consolidation of Company. For the purpose of this Warrant, “Acquisition” means any sale, license, or other disposition of all or substantially all of
the assets of Company, or any reorganization, 

  
 1 

 
consolidation, or merger of Company where the holders of Company’s securities before the transaction beneficially own less than 50% of the outstanding voting securities of the surviving
entity after the transaction. Upon the closing of any Acquisition, the successor entity shall assume the obligations of this Warrant, and this Warrant shall be exercisable for the same securities, cash, and property as would be payable for Shares
issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on the record date for the Acquisition and subsequent closing, and the Exercise Price shall be adjusted accordingly; provided that if pursuant to
such Acquisition the entire outstanding class of Shares issuable upon exercise of the unexercised portion of this Warrant are cancelled and the total consideration payable to the holders of such class of Shares consists entirely of cash, then, upon
payment to the holder of this Warrant of an amount equal to the amount such holder would receive if such holder hold Shares issuable upon exercise of the unexercised portion of this Warrant and such Shares were outstanding on the record date for the
Acquisition less the aggregate Exercise Price of such Shares, this Warrant shall be cancelled. 
  

	 ARTICLE 2
	 ADJUSTMENTS. 

 2.1 Stock Dividends, Splits, Etc. If Company declares or pays a dividend on its common stock payable in common stock or other securities, subdivides the outstanding common stock into a greater
amount of common stock, then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without cost to Holder, the total number and kind of securities to which Holder would have been entitled had Holder owned Shares of record as
of the date the dividend or subdivision occurred. 
 2.2 Reclassification, Exchange or Substitution.
Except in the case of an Acquisition to which Section 1.6 is applicable, upon any reclassification, exchange, substitution, or other event that results in a change of the number and/or class of the securities issuable upon exercise or
conversion of this Warrant, Holder shall be entitled to receive, upon exercise or conversion of this Warrant, the number and kind of securities and property that Holder would have received for Shares if this Warrant had been exercised immediately
before such reclassification, exchange, substitution, or other event. Company or its successor shall promptly issue to Holder a new Warrant for such new securities or other property. The new Warrant shall provide for adjustments which shall be as
nearly equivalent as may be practicable to the adjustments provided for in this Article 2 including, without limitation, adjustments to the Exercise Price and to the number of securities or property issuable upon exercise of the new Warrant The
provisions of this Section 2.2 shall similarly apply to successive reclassifications, exchanges, substitutions, or other events. 
 2.3 Adjustments for Combinations, Etc. If the outstanding Shares are combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Exercise Price shall be
proportionately increased and the number of Shares as to which this warrant is exercisable shall be proportionately decreased. 
 2.4 Adjustments for Diluting Issuances. The Exercise Price and the number of Shares issuable upon exercise of this Warrant or, if Shares are Preferred Stock, shall be subject to adjustment, from
time to time in the manner set forth on Exhibit A in the event of Diluting Issuances (as defined on Exhibit A). 

2.5 No Impairment. Company shall not, by amendment of its Articles/Certificate of Incorporation or through a
reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this
Warrant by Company, but shall at all times in good faith assist in carrying out of all the provisions of this Article 2 and in taking all such action as may be necessary or appropriate to protect Holder’s rights under this Article against
impairment. If Company takes any dilutive action affecting Shares or its common stock other than as described above that adversely affects Holder’s rights under this Warrant, the Exercise Price shall be adjusted downward and the number of
Shares issuable upon exercise of this Warrant shall be adjusted upward in such a manner that such dilutive action is offset and the aggregate Exercise Price of this Warrant is unchanged. 

2.6 Fractional Shares. No fractional Shares shall be issuable upon exercise or conversion of the Warrant and the
number of Shares to be issued shall be rounded down to the nearest whole Share. If a fractional share interest arises upon any exercise or conversion of the Warrant, Company shall eliminate such fractional share interest by paying Holder an amount
computed by multiplying the fractional interest by the fair market value of a full Share. 
 2.7 Certificate
as to Adjustments. Upon each adjustment of the Exercise Price, Company at its expense shall promptly compute such adjustment, and furnish Holder with a certificate of its Chief Financial Officer setting forth such adjustment and the facts upon
which such adjustment is based. Company shall, upon written request, furnish Holder a certificate setting forth the Exercise Price in effect upon the date thereof and the series of adjustments leading to such Exercise Price. 

  
 2 

	 ARTICLE 3
	 COVENANTS OF COMPANY. 

 3.1 Valid Issuance. Company shall take all steps necessary to insure that all Shares which may be issued upon the exercise of this Warrant, and all securities, if any, issuable upon conversion of
Shares, shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state securities laws.

 3.2 Notice of Certain Events. If Company proposes at any time (a) to declare any dividend or
distribution upon its common stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to offer for subscription pro rata to the holders of any class or series of its stock any additional
shares of stock of any class or series or other rights; (c) to effect any reclassification or recapitalization of common stock; (d) to merge or consolidate with or into any other corporation, or sell, lease, license, or convey all or
substantially all of its assets, or to liquidate, dissolve or wind up; or (e) offer holders of registration rights the opportunity to participate in an underwritten public offering of the company’s securities for cash, then, in connection
with each such event, Company shall give Holder (1) in the case of the matters referred to in (a) and (b) above at least 20 days prior written notice of the date on which a record will be taken for such dividend, distribution, or
subscription rights (and specifying the date on which the holders of common stock will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (c) and (d) above; (2) in the case of the
matters referred to in (c) and (d) above at least 20 days prior written notice of the date when the same will take place (and specifying the date on which the holders of common stock will be entitled to exchange their common stock for
securities or other property deliverable upon the occurrence of such event); and (3) in the case of the matter referred to in (e) above, the same notice as is given to the holders of such registration rights. 

3.3 Information. So long as the Holder holds this Warrant and/or any of the Shares, Company shall deliver to
Holder (a) promptly, copies of all notices or other written communications to which Holder would be entitled if it held Shares as to which this Warrant was then exercisable and (b) such other financial statements required under and in
accordance with any loan documents between Holder and Company, or if there are no such requirements or if the subject loan(s) are no longer are outstanding, then within 45 days after the end of each of the first three quarters of each fiscal year,
Company’s quarterly, unaudited financial statements and within 90 days after the end of each fiscal year, Company’s annual, audited financial statements. 

3.4 Notice of Expiration. Company shall give Holder written notice of Holder’s right to exercise this Warrant
in the form attached as Appendix 2 not more than 90 days and not less than 15 days before the Expiration Date and, in the case of an Acquisition to which the proviso of Section 1.6 shall be applicable, 15 days notice of such Acquisition. If the
notice is not so given, the Expiration Date shall automatically be extended until 15 days after the date Company delivers the notice to Holder. 
 3.5 Registration Rights. The Shares, or the common stock into which the Shares are convertible, shall have the same “piggyback” registration rights as are set forth in the Investor Rights
Agreement, dated as of [                    ], between Company and its investors, as from time to time in effect (the “Investor
Rights Agreement” – a true copy of which as in effect on the date hereof has been furnished by Company to Holder). Company agrees that no amendments will be made to the Investor Rights Agreement which would have an adverse impact on
Holder’s registration rights thereunder. 
 3.6 Information Rights. So long as the Holder holds this
Warrant and/or any of the Shares, the Company shall deliver to the Holder (a) within ninety (90) days after the end of each fiscal year of the Company, the annual audited financial statements of the Company certified by independent public
accountants of recognized standing and (b) within forty-five (45) days after the end of each of the first three quarters of each fiscal year, the Company’s quarterly, unaudited financial statements, provided Company need not provide
such information for any period in which Company has filed Form 10Q with the Securities and Exchange Commission. 
  

	 ARTICLE 4
	 MISCELLANEOUS. 

 4.1 Term. This Warrant is exercisable, in whole or in part, at any time and from time to time on or before the Expiration Date set forth above. 

  
 3 

 4.2 Legends. This Warrant and the Shares (and the securities
issuable, directly or indirectly, upon conversion of Shares, if any) shall be imprinted with a legend in substantially the following form: 
 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR
PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO COMPANY AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED. 
 4.3 Compliance with Securities Laws on Transfer. This Warrant and the Shares issuable upon exercise of this Warrant (and the securities issuable, directly or indirectly, upon conversion of Shares,
if any) may not be transferred or assigned in whole or in part without compliance with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation
letters and legal opinions reasonably satisfactory to Company, as reasonably requested by Company). Company shall not require Holder to provide an opinion of counsel if the transfer is to an affiliate of Holder or if there is no material question as
to the availability of current information as referenced in Rule 144(c), Holder represents that it has complied with Rule 144(d) and (e) in reasonable detail, the selling broker represents that it has complied with Rule 144(f), and the Company
is provided with a copy of Holder’s notice of proposed sale. 
 4.4 Transfer Procedure. Subject to
the provisions of Section 4.3 Holder may transfer all or part of this Warrant or the Shares issuable upon exercise of this Warrant (or the securities issuable, directly or indirectly, upon conversion of Shares, if any) at any time to any other
transferee acceptable to Company (which acceptance shall not be unreasonably withheld or delayed) by giving Company notice of the portion of the Warrant being transferred setting forth the name, address and taxpayer identification number of the
transferee and surrendering this Warrant to Company for reissuance to the transferee(s) (and Holder if applicable). Unless Company is filing financial information with the SEC pursuant to the Securities Exchange Act of 1934, Company shall have the
right to refuse to transfer any portion of this Warrant to any person who directly competes with Company 
 4.5
Notices. All notices and other communications from Company to Holder, or vice versa, shall be in writing and shall be deemed delivered and effective when given personally or mailed by first-class registered or certified mail, postage prepaid,
or by overnight courier, at such address as may have been furnished to Company or Holder, as the case may be, in writing by Company or such Holder from time to time. 

4.6 Attorneys Fees. In the event of any dispute between the parties concerning the terms and provisions of this
Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred to such dispute, including reasonable attorneys’ fees. 

4.7 Waiver. This Warrant and any term hereof may be changed, waived, discharged or terminated only by an
instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought. 
 4.8 Governing Law. This Warrant shall be governed by and construed in accordance with the laws of the State of California, without giving effect to its principles regarding conflicts of law.

 IN WITNESS WHEREOF, Company has caused this Warrant to be duly executed by its authorized officers, all as of
the day and year first above written. 

  
 4 

 
			
	 COMPANY

	 GIGOPTIX, INC.

		
	 By:
	 	 /s/ Ron Shelton

	 Name:
	 	 Ron Shelton

	 Title:
	 	 CFO

  
 5 

 APPENDIX 1 
 Notice of Exercise 
 [Strike paragraph that does not apply.] 

1. The undersigned hereby elects to purchase              shares of
the Common/Series              Preferred [strike one] Stock of
                                        
pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price of such shares in full. 
 1.
The undersigned hereby elects to convert the attached Warrant into Shares/cash [strike one] in the manner specified in the Warrant This conversion is exercised with respect to
                                        
of the Shares covered by the Warrant. 
 2. Please issue a certificate or certificates representing said shares in the name of
the undersigned or in such other name as is specified below: 
  

			
	 Name:
	 	  

		
	 Address:
	 	  

		
		 	  

3. The undersigned represents it is acquiring the shares solely for its own account and not as a nominee for any other party and not with
a view toward the resale or distribution thereof except in compliance with applicable securities laws. 
  

	
	  

	 (Signature)

	  

	 (Date)

  
 6 

 APPENDIX 2 
 Notice that Warrant Is About to Expire 
 [Insert Date of Notice] 

 

			
	 To:
	    	 Bridge Bank, National Association

		    	 Attn:
                                    

		    	 55 Almaden Boulevard, Suite 100

		    	 San Jose, California 95113

 The Warrant issued to you described below will expire on             ,     . 

Issuer: 
 Issue
Date: 
 Class of Security Issuable: 
 Exercise Price per Share: 
 Number of Shares Issuable: 

Procedure for Exercise: 
 Please contact                      at (    )
    -    with any questions you may have concerning exercise of the Warrant. This 
 is your only notice of pending expiration. 
  

			
	  

	 (Name of Issuer)

	 By
	 	  

	 Its:
	 	  

  
 7 

 EXHIBIT A 
 Anti-Dilution Provisions 
 (For Common Stock Warrants Where 

Anti-Dilution Protection is Inadequate or Non-existent) 

In the event of the issuance (a “Diluting Issuance”) by Company, after the Issue Date of the Warrant, of Common
Stock (or options or other rights to subscribe thereto or securities convertible into or exchangeable for Common Stock) at a price per share less than the Exercise Price or less than the fair market value of the Common Stock at the date of such
issuance, then the number of Shares issuable upon exercise of the Warrant and the Exercise Price, shall be adjusted as a result of Diluting Issuances in accordance with the following (provided that under no circumstances shall the aggregate
Exercise Price payable by Holder upon exercise of the Warrant increase as a result of any adjustment arising from a Diluting Issuance): 
 1. Definitions. As used in these Antidilution Provisions, the following terms have the following respective meanings: 

(a) “Option” means any right, option, or warrant to subscribe for, purchase, or otherwise acquire common stock
or Convertible Securities. 
 (b) “Convertible Securities” means any evidences of indebtedness, shares
of stock, or other securities directly or indirectly convertible into or exchangeable for common stock. 
 (c)
“Issue”, means to grant, issue, sell, assume, or fix a record date for determining persons entitled to receive, any security (including Options), whichever of the foregoing is the first to occur. Any variation of the term “Issue”
including, without limitation, “Issuable”, “Issuance” or “Issued” shall have the same meaning as set forth in this section 1(c). 
 (d) “Additional Common Shares” means all common stock (including reissued shares) issued (or deemed to be issued pursuant to Section 2) after the date of the Warrant. Additional Common
Shares does not include, however, any common stock issued in a transaction described in Sections 2.1 and 2.2 of the Warrant; any common stock Issued upon conversion of preferred stock outstanding on the date of the Warrant; the Shares; or common
stock Issued as incentive or in a nonfinancing transaction to employees, officers, directors, or consultants to Company. 
 (e) The shares of common stock ultimately Issuable upon exercise of an Option (including the shares of common stock ultimately Issuable upon conversion or exercise of a Convertible Security Issuable
pursuant to an Option) are deemed to be Issued when the Option is Issued. The shares of common stock ultimately Issuable upon conversion or exercise of a Convertible Security (other than a Convertible Security Issued pursuant to an Option) shall be
deemed Issued upon Issuance of the Convertible Security. 
 2. Deemed Issuance of Additional Common Shares. The shares of
common stock ultimately Issuable upon exercise of an Option (including the shares of common stock ultimately Issuable upon conversion or exercise of a Convertible Security Issuable pursuant to an Option) are deemed to be Issued when the Option is
Issued. The shares of common stock ultimately Issuable upon conversion or exercise of a Convertible Security (other than a Convertible Security Issued pursuant to an Option) shall be deemed Issued upon Issuance of the Convertible Security. The
maximum amount of common stock Issuable is determined without regard to any future adjustments permitted under the instrument creating the Options or Convertible Securities. 
 3. Adjustment of Exercise Price for Diluting Issuances 

3.1 Weighted Average Adjustment. If Company issues Additional Common Shares after the date of the Warrant and the
consideration per Additional Common Share (determined pursuant to Section 9) is less than the Exercise Price in effect immediately before such Issue, the Exercise Price shall be reduced, concurrently with such Issue, to a price (calculated to
the nearest hundredth of a cent) determined by multiplying the Exercise Price by a fraction: 
 (a) the
numerator of which is the amount of such common stock outstanding immediately before such Issue plus the amount of common stock that the aggregate consideration received by Company for the Additional Common Shares would purchase at the Exercise
Price in effect immediately before such Issue, and 

  
 1 

 (b) the denominator of which is the amount of common stock outstanding
immediately before such Issue plus the number of such Additional Common Shares. 
 3.2 Adjustment of Number
of Shares. Upon each adjustment of the Exercise Price, the number of Shares issuable upon exercise of the Warrant shall be increased to equal the quotient obtained by dividing (a) the product resulting from multiplying (i) the number
of Shares issuable upon exercise of the Warrant and (ii) the Exercise Price, in each case as in effect immediately before such adjustment, by (b) the adjusted Exercise Price. 

3.3 Securities Deemed Outstanding. For the purpose of this Section 3, all securities issuable upon exercise
of any outstanding Convertible Securities or Options, warrants, or other rights to acquire securities of Company shall be deemed to be outstanding. 
 4. No Adjustment for Issuances Following Deemed Issuances. No adjustment to the Exercise Price shall be made upon the exercise of Options or conversion of Convertible Securities. 

5. Adjustment Following Changes in Terms of Options or Convertible Securities. If the consideration payable to, or the amount of
common stock Issuable by, Company increases or decreases, respectively, pursuant to the terms of any outstanding Options or Convertible Securities, the Exercise Price shall be recomputed to reflect such increase or decrease. The recomputation shall
be made as of the time of the Issuance of the Options or Convertible Securities. Any changes in the Exercise Price that occurred after such Issuance because other Additional Common Shares were Issued or deemed Issued shall also be recomputed.

 6. Recomputation Upon Expiration of Options or Convertible Securities. The Exercise Price computed upon the original
Issue of any Options or Convertible Securities, and any subsequent adjustments based thereon, shall be recomputed when any Options or rights of conversion under Convertible Securities expire without having been exercised. In the case of Convertible
Securities or Options for common stock, the Exercise Price shall be recomputed as if the only Additional Common Shares Issued were the shares of common stock actually Issued upon the exercise of such securities, if any, and as if the only
consideration received therefor was the consideration actually received upon the Issue, exercise or conversion of the Options or Convertible Securities. In the case of Options for Convertible Securities, the Exercise Price shall be recomputed as if
the only Convertible Securities Issued were the Convertible Securities actually Issued upon the exercise thereof, if any, and as if the only consideration received therefor was the consideration actually received by Company (determined pursuant to
Section 9), if any, upon the Issue of the Options for the Convertible Securities. 
 7. Limit on Readjustments. No
readjustment of the Exercise Price pursuant to Sections 5 or 6 shall increase the Exercise Price more than the amount of any decrease made in respect of the Issue of any Options or Convertible Securities. 

8. 30 Day Options. In the case of any Options that expire by their terms not more than 30 days after the date of Issue thereof, no
adjustment of the Exercise Price shall be made until the expiration or exercise of all such Options. 
 9. Computation of
Consideration. The consideration received by Company for the Issue of any Additional Common Shares shall be computed as follows: 
 (a) Cash shall be valued at the amount of cash received by Company, excluding amounts paid or payable for accrued interest or accrued dividends. 

(b) Property. Property other than cash shall be computed at the fair market value thereof at the time of the Issue
as determined in good faith by the Board of Directors of Company. 
 (c) Mixed Consideration. The
consideration for Additional Common Shares Issued together with other property of Company for consideration that covers both shall be determined in good faith by the Board of Directors of Company. 

(d) Options and Convertible Securities. The consideration per Additional Common Share for Options and Convertible
Securities shall be determined by dividing: 
 (i) the total amount, if any, received or receivable by Company
for the Issue of the Options or Convertible Securities, plus the minimum amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such
consideration) payable to Company upon exercise of the Options or conversion of the Convertible Securities, by 

  
 2 

 (ii) the maximum amount of common stock (as set forth in the instruments
relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) ultimately Issuable upon the exercise of such Options or the conversion of such Convertible Securities. 

  
 3Registration Rights Agreement

 Exhibit 10.23 
 REGISTRATION RIGHTS AGREEMENT 
 This
REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of the 30th day of June, 2010, by and among GIGOPTIX, INC., a Delaware corporation (the “Company”), and JAMES R. ZAZZALI, as trustee (the Trustee”) for the Chapter 11 debtors
(collectively, the “DBSI Entities”) in the matter In re: DBSI, Inc., et al., Case No. 08-12687 (PJW), pending in the United States Bankruptcy Court for the District of Delaware (the “Court”) 

Recitals 
 A. As of the date hereof, the DBSI Entities indirectly hold an aggregate of 1,715,161 shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company
(collectively, the “Shares”). 
 B. The Company seeks to sell up to $18,000,000 of Common
Stock in a registered offering (the “Registered Offering”) under the Securities Act of 1933, as amended (the “1933 Act”), that will be underwritten by Roth Capital Partners, LLC (“Roth”).

 C. To induce Roth to serve as underwriter for the Registered Offering, the Trustee has entered into a Lock-Up
Agreement and an accompanying letter agreement, each dated as of June 30, 2010 (collectively, the “Lock-Up Agreement”), whereby the Shares will be subject to a 180-day lock-up following the close of the Registered Offering,
during which period the Trustee will be restricted from transferring or disposing of the Shares subject to certain exceptions, as more particularly set forth in the Lock-Up Agreement. 

D. In connection with the Lock-Up Agreement, the Company desires to provide to the Trustee certain registration rights
with respect to the Shares under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, and applicable state securities laws. 

Now, therefore, in consideration of the foregoing and the mutual promises contained herein, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Trustee agree as follows: 
 Agreement 

1. Definitions. For purposes of this Agreement, capitalized terms used herein but not otherwise defined shall have the meaning
given to them in the Lock-Up Agreement, and the following terms shall have the meanings given them: 
 1.1.
“Affiliate” means, with respect to any Person, any other Person which, directly or indirectly through one or more intermediaries, Controls, is controlled by, or is under common control with, such Person. 

1.2. “Business Day” means a day, other than a Saturday or Sunday on which banks in California are open for the
general transaction of business. 

  
 1 

 1.3. “Control” (including the terms “controlling,”
“controlled by” or “under common control with”) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting
securities, by contract or otherwise. 
 1.4. “Damages” means any loss, damage, or liability to which
a party hereto may become subject under the 1933 Act, the 1934 Act, or other federal or state law, insofar as such loss, damage, or liability (or any action in respect thereof) arises out of or is based upon (a) any untrue statement or alleged
untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto; (b) an omission or alleged omission
to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or (c) any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the 1933
Act, the 1934 Act, any state securities law, or any rule or regulation promulgated under the 1933 Act, the 1934 Act, or any state securities law. 
 1.5. “Holder” means the Trustee, any successor to the Trustee appointed by the Court pursuant to a Plan of Liquidation or otherwise, any Affiliate of the DBSI Entities which is a holder of
Registrable Securities, any permitted transferees of any of the foregoing, and any Person acquiring any of the Shares pursuant to the terms of the letter agreement with Roth accompanying the Lock-Up Agreement who agrees in writing to be bound by and
subject to the terms and conditions of this Agreement. 
 1.6. “Person” means an individual,
corporation, partnership, limited liability company, trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed
herein. 
 1.7. “Registrable Securities” means (a) the Shares and (b) any Common Stock
issued as a dividend or other distribution with respect to, or in exchange for or in replacement of, the Common Stock referenced in clause (a) above, including, without limitation, any Common Stock which is issued to any Holder subsequent to
the conversion resulting from any stock split or merger. 
 1.8. “SEC” means the Securities and
Exchange Commission. 
 1.9. “Rule 144” means Rule 144 promulgated by the SEC under the 1933 Act.

 1.10. “Selling Expenses” means all underwriting discounts, selling commissions, and stock transfer
taxes applicable to the sale of Registrable Securities, and shall include fees and disbursements of counsel for any Holder (except for such fees and disbursements of counsel for the Holders as provided in Section 2.4). 

1.11. “1934 Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules
and regulations promulgated thereunder. 

  
 2 

 2. Registration Rights. The Company covenants and agrees as follows: 

2.1. Registration. The Company shall cause the Registrable Securities held by a Holder to be registered under the
1933 Act so as to permit the resale thereof, and in connection therewith, shall use all commercially reasonable best efforts to prepare and file a registration statement on Form S-1 or such other form for which the Company may be eligible under the
1933 Act (the “Registration Statement”) with the SEC within ten (10) Business Days following the expiration of the Lock-Up Period (as defined in the Lock-Up Agreement), and use all commercially reasonable best efforts to cause
the Registration Statement to become effective as soon as possible after the filing thereof. Each Holder shall provide all such information and materials to the Company and take all such action as may be required in order to permit the Company to
comply with all applicable requirements of the SEC and to obtain any desired acceleration of the effective date of such Registration Statement. Such provision of information and materials is a condition precedent to the obligations of the Company
with respect to such Holder pursuant to this Section 2. 
 2.2. Obligations of the Company. In
connection with the registration of the Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) use its commercially reasonable best efforts to prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable best efforts to
cause such registration statement to become effective and keep such registration statement effective until the later to occur of (i) the expiration of one year or, if earlier, such time that the distribution contemplated by the registration
statement has been completed, and (ii) such time that the Registrable Securities may be resold by the Holder without restriction under Rule 144; 

(b) use its commercially reasonable best efforts to prepare and file with the SEC such amendments and
supplements to such registration statement, and the prospectus used in connection with such registration statement, as may be necessary to comply with the 1933 Act in order to enable the disposition of all securities covered by such registration
statement; 
 (c) furnish to the selling Holders such numbers of copies of a prospectus,
including a preliminary prospectus, as required by the 1933 Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 

(d) use its commercially reasonable best efforts to register and qualify the securities covered by such
registration statement under such other securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a general consent
to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the 1933 Act; 

  
 3 

 (e) provide a transfer agent and registrar for all
Registrable Securities registered pursuant to this Agreement and provide a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration statement; and 

(f) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such
registration statement has been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed. 
 2.3. Furnish Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to Section 2 with respect to the Registrable Securities of any selling
Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required to effect the registration of such
Holder’s Registrable Securities. 
 2.4. Expenses of Registration. All expenses (other than Selling
Expenses) incurred in connection with registrations, filings, or qualifications pursuant to Section 2, including all registration, filing, and qualification fees; printers’ and accounting fees; and fees and disbursements of counsel for the
Company, shall be borne and paid by the Company. All Selling Expenses relating to Registrable Securities registered pursuant to Section 2 shall be borne and paid by the Holders pro rata on the basis of the number of Registrable Securities being
registered on their behalf. 
 2.5. Indemnification. If any Registrable Securities are included in a
registration statement under this Section 2: 
 (a) To the extent permitted by law, the
Company will indemnify and hold harmless each selling Holder, and the partners, members, officers, directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the 1933 Act) for
each such Holder; and each Person, if any, who controls such Holder or underwriter within the meaning of the 1933 Act or the 1934 Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other
aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity
agreement contained in this Section 2.5(a) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor
shall the Company be liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of any such Holder, underwriter,
controlling Person, or other aforementioned Person expressly for use in connection with such registration. 
 (b) To the extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, and each of its directors, each of

  
 4 

 
its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the 1933 Act, legal counsel and accountants for the Company, any
underwriter (as defined in the 1933 Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other Holder, against any Damages, in each case only to the extent that such Damages
arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly for use in connection with such registration; and each such selling
Holder will pay, severally and not jointly, to the Company and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may
result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Section 2.5(b) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the
consent of such Holder, which consent shall not be unreasonably withheld; and further provided, however, that any liability with respect to this Section 2.5(b) shall be limited to the proceeds of sale of Registrable Securities. 

(c) Promptly after receipt by an indemnified party under this Section 2.5 of notice of the
commencement of any action (including any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this
Section 2.5, give the indemnifying party notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other
indemnifying party to which notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented
without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party
would be inappropriate due to actual or potential conflicting interests between such indemnified party and any other party represented by such counsel in such action. The failure to give notice to the indemnifying party within a reasonable time of
the commencement of any such action shall not relieve such indemnifying party of any liability to the indemnified party under this Section 2.5 unless such failure actually and materially prejudices the indemnifying party’s ability to
defend such action. 
 (d) Notwithstanding anything else herein to the contrary, the foregoing
indemnity agreements of the Company and the selling Holders are subject to the condition that, insofar as they relate to any Damages arising from any untrue statement or alleged untrue statement of a material fact contained in, or omission or
alleged omission of a material fact from, a preliminary prospectus (or necessary to make the statements therein not misleading) that has been corrected in the form of prospectus included in the registration statement at the time it becomes
effective, or any amendment or supplement thereto filed with the SEC pursuant to Rule 424(b) under the 1933 Act (the “Final Prospectus”), such indemnity agreement shall not inure to the benefit of any Person if a copy of the Final
Prospectus was furnished to the indemnified party and such indemnified 

  
 5 

 
party failed to deliver, at or before the confirmation of the sale of the shares registered in such offering, a copy of the Final Prospectus to the Person asserting the loss, liability, claim, or
damage in any case in which such delivery was required by the 1933 Act. 
 (e) To provide for
just and equitable contribution to joint liability under the 1933 Act in any case in which either (i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Section 2.5 but it is
judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case,
notwithstanding the fact that this Section 2.5 provides for indemnification in such case, or (ii) contribution under the 1933 Act may be required on the part of any party hereto for which indemnification is provided under this
Section 2.5, then, and in each such case, such parties will contribute to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to
reflect the relative fault of each of the indemnifying party and the indemnified party in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other
relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the
omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent
such statement or omission; provided, however, that, in any such case, no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) will be entitled to contribution from any Person who was not guilty of
such fraudulent misrepresentation. 
 (f) The obligations of the Company and Holders under this
Section 2.5 shall survive the completion of any offering of Registrable Securities in a registration under Section 2, and otherwise shall survive the termination of this Agreement. 

2.6. Current Public Information. With a view to making available to the Holders the benefits of Rule 144 under the
1933 Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration, the Company shall: 

(a) make and keep available adequate current public information, as those terms are understood and defined
in Rule 144, at all times; and 
 (b) furnish to any Holder, so long as the Holder owns any
Registrable Securities, upon request (A) to the extent accurate, a written statement by the Company that it has complied with the reporting requirements of Rule 144; (B) a copy of the most recent annual or quarterly report of the Company
and such other reports and documents so filed by the Company; and (C) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without
registration. 

  
 6 

 2.7. Suspension of Registration Rights. Notwithstanding any other
provision of this Section 2, the Company shall have the right at any time to require that all Holders suspend further open market offers and sales of Registrable Securities for a period not to exceed ninety (90) days, if, in the reasonable
judgment of the Company after consultation with counsel, there is in existence material undisclosed information or events with respect to the Company, the disclosure of which would be seriously detrimental to the Company (the “Suspension
Right”); provided, however, that the Company shall not exercise this Suspension Right more than once in any twelve (12) month period; and further provided, that the Company shall not exercise this Suspension Right within the first 90
days following the effective date of the Registration Statement without consultation with, and approval from, the Holders. In the event the Company exercises the Suspension Right, such suspension will continue for the period of time reasonably
necessary for disclosure to occur at a time that is not materially detrimental to the Company or until such time as the information or event is no longer material, each as determined in good faith by the Company after consultation with counsel, but
in no event shall any single suspension continue for more than 90 consecutive days. The Company will promptly give notice, in a writing signed by an executive officer of the Company of any such suspension (the “Suspension Notice”).
The Company agrees to notify the Holders promptly upon termination of the suspension (the “Resumption Notice”). 
 3. Affirmative Covenants. 
 3.1. Institutional
Placements; No Adverse Effect. Upon the registration of the Registrable Securities, no selling Holder shall, within the first 12 months following the effectiveness of such registration (the “Institutional Placement Period”),
sell, transfer or otherwise dispose of such Registrable Securities except in institutional placements (each, a “Disposition”) and further, each such Disposition shall be subject to the Company’s sole and exclusive determination
that such Disposition shall not have an adverse effect on the price at which the Common Stock trades. In connection with any public offering by the Company during the Institutional Placement Period involving an underwriting of Common Stock (but
excluding any registration statement on Form S-4 or otherwise intended to effect a business combination), the Registrable Securities may be concurrently offered by the underwriters as placement agent for the Holders together with Common Stock
offered by the Company if the Holders accept the underwriting as agreed upon by the Company and the underwriters selected by the Company; subject to the determination by the underwriters in their sole discretion that such inclusion of the
Registrable Securities will not jeopardize the success of the offering by the Company. 
 4. Miscellaneous. 

4.1. Successors and Assigns. Except as set forth in this Section 4.1, this Agreement shall not be assignable
by any Holder without the prior written consent of the Company. Prior written consent will not be required for any assignment of this Agreement by a Holder to an Affiliate assignee or to any successor of the Trustee appointed by the Court or
otherwise or to any Person acquiring any of the Shares pursuant to the terms of the letter agreement with Roth accompanying the Lock-Up Agreement; provided that such transfer provides that (i) the Company is, within a reasonable period of time
after such transfer, furnished with written notice of the name and address of the Affiliate and (ii) the Affiliate agrees in a written instrument, satisfactory to the Company, to be bound by and subject to the terms and conditions of this

  
 7 

 
Agreement. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assignees any rights,
remedies, obligations or liabilities under or by reason of this Agreement. 
 4.2. Governing Law. This
Agreement shall be governed by, and construed in accordance with, the internal laws of the State of California without regard to the choice of law principles thereof. The United States Bankruptcy Court for the District of Delaware shall have
exclusive jurisdiction for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of process in connection with any such suit, action or proceeding may
be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any such suit, action
or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit,
action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN
CONSULTED SPECIFICALLY AS TO THIS WAIVER. 
 4.3. Counterparts; Facsimile. This Agreement may be
executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Agreement may also be executed via facsimile, which shall be deemed an original.

 4.4. Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience
only and are not to be considered in construing or interpreting this Agreement. 
 4.5. Notices. Unless
otherwise provided, any notice required or permitted under this Agreement shall be given in writing and shall be deemed effectively given as hereinafter described (i) if given by personal delivery, then such notice shall be deemed given upon
such delivery, (ii) if given by telex or telecopier, then such notice shall be deemed given upon receipt of confirmation of complete transmittal, (iii) if given by mail, then such notice shall be deemed given upon the earlier of
(A) receipt of such notice by the recipient or (B) three days after such notice is deposited in first class mail, postage prepaid, and (iv) if given by an internationally recognized overnight air courier, then such notice shall be
deemed given one (1) Business Day after delivery to such carrier. All notices shall be addressed to the party to be notified at the address as follows, or at such other address as such party may designate by ten days’ advance written
notice to the other party: 
 If to the Company: 

GigOptix, Inc. 
 2300 Geng Road, Suite 250 
 Palo Alto, CA 94303 

Attention: Chief Executive Officer 

Telecopier No.: (650) 424-1938 

  
 8 

 with a copy to: 

Jeffrey C. Selman, Esq. 
 Nixon Peabody, LLP 
 2 Palo Alto Square 

3000 El Camino Real, Suite 500 
 Palo Alto, CA 94306 
 Telecopier No.: (866) 438-3891

 If to the Trustee: 
 c/o Gibbons P.C. 
 1 Gateway Center 

Newark, NJ 07102 
 Telecopier No.: (973) 639-6483 
 with copies to: 

Lawrence A. Goldman, Esq. (Counsel to Trustee) 

Gibbons P.C. 
 1 Gateway Center 
 Newark, NJ 07102 

Telecopier No.: (973) 639-6283 

Michael Goldstein, Esq. (Counsel to Creditors Committee) 

Greenberg Traurig LLP 
 2450 Colorado Ave. 
 Suite 400E 

Santa Monica, CA 90404 
 Telecopier No.: (310) 586-7800 
 4.6. Amendments and
Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the
Company and the Trustee. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each Holder of any Registrable Securities at the time outstanding, and the Company. 

4.7. Severability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall,
as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted as if it were written so as to be enforceable to the maximum extent permitted
by applicable law, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent permitted by applicable law, the parties hereby waive any
provision of law which renders any provision hereof prohibited or unenforceable in any respect. 

  
 9 

 4.8. Entire Agreement. This Agreement constitutes the entire
agreement among the parties hereof with respect to the subject matter hereof and supersedes all prior agreements and understandings, both oral and written, between the parties with respect to the subject matter hereof. 

4.9. Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party under
this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or acquiescence to any such
breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies, whether under this
Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 
 [signature page
follows] 

  
 10 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their
duly authorized officers to execute this Agreement as of the date first above written. 
  

					
	 The Company:
	 	 GIGOPTIX, INC.

			
		 	 By:
	 	 /s/ Avi Katz

		 	 Name:
	 	 Avi Katz

		 	 Title:
	 	 Chief Executive Officer

			
	 The Trustee:
	 	 By:
	 	 /s/ James R. Zazzali

		 	 Name:
	 	 James R. Zazzali

		 	 Title:
	 	 Chapter 11 Trustee for DBSI, Inc. et als.

 Signature Page to Registration Rights Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}]]